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Osteochondral Lesion of the Talus
Could Age Be an Indication for Arthroscopic Treatment?
Woo Jin Choi,* MD, Bom Soo Kim,y MD, and Jin Woo Lee,*z MD, PhD
Investigation performed at Yonsei University College of Medicine, Seoul, South Korea
Background: Several studies have addressed the issue of the feasibility of arthroscopic surgery in older patients, usually by
choosing an arbitrary age limit.
Hypothesis: Patient age is not associated with poor clinical outcome after arthroscopic surgery for osteochondral lesion of the
talus (OLT), and other patient variables are the major determinants of clinical success/failure.
Study Design: Cohort study; Level of evidence, 3.
Methods: Between 2001 and 2008, 173 ankles underwent arthroscopic marrow stimulation treatment for OLT and were stratified
into 6 age groups (\20, 20-29, 30-39, 40-49, 50-59, and 60 years). Bivariate and multivariate analyses were performed to deter-
mine the effect of age on clinical outcome.
Results: There were no significant differences among the 6 age groups in the preoperative and postoperative visual analog scale (VAS)
for pain or the American Orthopaedic Foot and Ankle Society (AOFAS) score. There was a significant increase in the duration of symp-
toms (P\ .001) and a significant decrease in the incidence of trauma (P = .01) in the older group. Both the size of the osteochondral
defect and the number of associated intra-articular lesions independently predicted a poor clinical outcome (P\ .001).
Conclusion: In contrast to some of the previous studies on this topic, we found that increased age was not an independent risk
factor for poor clinical outcome after arthroscopic treatment for OLT. We did find that older patients were less likely to have a
history of trauma and had a longer duration of symptoms, had smaller osteochondral defects, and had more associated intra-
articular lesions.
Keywords: ankle; osteochondral lesion; age; clinical outcome
Osteochondral lesions of the talus (OLT) are common inju-
ries that are often found in patients with chronic disabling
pain after ankle sprains.1,3 The technique of arthroscopic
marrow stimulation is an established procedure for this
condition. While OLT is becoming increasingly prevalent
in the older population, there is disagreement among sur-
geons about the outcomes of arthroscopic surgery in older
patients. Several recent studies have indicated that older
patients seem to do well with arthroscopic treatment for
OLT,6,10,14,24 while others have reported less favorable out-
comes in older patients.7,11,17
Most of these studies used an arbitrary age limit as
a cutoff to define ‘‘older’’ patients (50, 55, 60, or 65 years)
and evaluated patient outcomes comparing these patients
with their younger counterparts. The lack of consistency
between studies in defining what is an older patient and
the inconsistent findings in general make these studies dif-
ficult to compare and critically evaluate.
The goals of this study were to examine trends in patient
characteristics, clinical outcomes, and arthroscopic findings
that occur with increasing age in a large series of patients
divided into 6 different age groups. We used a multivariate
analysis to determine the independent effect of age on clinical
outcome after controlling for other important covariates.
MATERIALS AND METHODS
We analyzed 170 patients (173 cases) who had a diagnosis
of OLT and were treated with arthroscopic marrow stimu-
lation between January 2001 and December 2008. We
obtained approval from the Institutional Review Board to
perform a retrospective review of patients who had local-
ized defects on the talar dome with symptoms of ankle
pain and/or functional limitations despite a minimum of
6 months of nonsurgical management. The study was fur-
ther limited to primary cases with no previous surgical
treatment, and patients with diffuse arthritic changes or
associated ankle fractures were excluded.
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Clinical Analysis
Patients were divided into 6 age groups:\20 years, 20 to 29
years, 30 to 39 years, 40 to 49 years, 50 to 59 years, and 60
years. All analyses were performed with these categorical age
groups. Bivariate and multivariate analyses (see statistical
methods below) were used to determine the effect of age on
the following outcome measures: (1) visual analog scale
(VAS) for pain and (2) American Orthopaedic Foot and Ankle
Society (AOFAS) Ankle-Hindfoot Score.15 All patients were
asked to fill out a questionnaire composed of questions
regarding the duration of their symptoms and the intensity
of pain during daily activities and exercise before surgery;
6 weeks, 6 months, 1 year, and 2 years after surgery; and
at final follow-up. The clinical results at the final follow-up
were graded according to the criteria of Saxena and Eakin25
(excellent, 90-100; good, 80-89; fair, 70-79; and poor, \70).
Treatment was designated as successful if patients did not
require osteochondral transplantation and in those with an
AOFAS score of 80 or greater, while clinical failure was
defined as patients having fair or poor outcomes (AOFAS
score\80) or needing osteochondral transplantation.
Radiological Analysis
We also sought to determine the relationships between
defect size, associated intra-articular lesions, and age and
clinical outcome after arthroscopic treatment. In each
patient, we obtained anteroposterior and lateral weightbear-
ing radiographs and magnetic resonance imaging (MRI)
scans to assess the size of the osteochondral defect and the
associated intra-articular abnormality. The size of the osteo-
chondral lesion was measured by preoperative MRI as
described in our previous study.6 To avoid potential bias,
an independent observer who was not involved in the care
of the patients and blinded to the intention of this study
evaluated the magnetic resonance images. The location of
the lesion was described as medial or lateral on coronal
images and anterior, center, or posterior on sagittal images.
Surgical Technique
The arthroscopic procedure was performed in a standard-
ized manner in every case. The procedure consists of the
accurate debridement of all unstable and damaged carti-
lage in the lesion, including the calcified layer down to
the subchondral bone plate. A microfracture awl (Linvatec,
Largo, Florida) was then used to make multiple holes in
the defect, 3 to 4 mm apart in areas where the subchondral
bone was intact. For areas with subchondral bone loss,
chondroplasty was performed with a ring-shaped or curved
curette. Associated lesions, including the presence of ankle
instability, subchondral cysts, impingement syndrome,
and distal tibial plafond lesions, were checked, and treat-
ment modalities were also noted. After the operation, we
recommended tolerable weightbearing for patients with
lesions smaller than 1.5 cm2. Those with larger lesions
were restricted to partial weightbearing for 3 weeks.6,13
For 37 patients with lateral ligament reconstruction,
a postoperative short leg walking cast with partial
weightbearing for 4 weeks was followed by joint motion
and muscle strengthening exercise for 8 weeks.5,12,21,22,24
Sports or high-impact activities were limited for at least
3 months.
Statistical Analysis
The outcome measures of interest were compared among
the 6 age groups. x2 analysis was used to compare propor-
tions for all categorical data. The reported x2 P values rep-
resent an overall test for differences between the 6 groups,
and pairwise comparisons were not performed. The actual
data are shown so that the readers could see where the dif-
ferences exist. All means are reported as mean 6 standard
deviation. The Kruskal-Wallis test was used to compare
means among the 6 age groups for all continuous variables.
P values represent an overall test for any differences among
the 6 groups. Significance was accepted at P\ .05. Multi-
variate logistic regression models were used to assess the
independent effect of age on clinical outcome. All multivar-
iate models were controlled for differences in demographic
factors, duration of symptoms, history of trauma, size of
the osteochondral defect, location of the lesions, and associ-
ated intra-articular lesions among the 6 age groups. For the
logistic regression models, we reported odds ratios and 95%
confidence intervals (CIs) relative to a chosen reference
group. All statistical analyses were performed by a statisti-
cian using SPSS statistical software (version 12.0.1, SPSS
Inc, an IBM Company, Chicago, Illinois).
RESULTS
The demographic data, duration of symptoms, history of
trauma, the size and location of the osteochondral defect,
and the number and type of associated intra-articular
lesions are listed in Table 1. Patients were divided into 6
age groups for the analysis. Patients younger than 20
years of age made up 11.6% of the patient population
(n = 20), while 26% (n = 45) were 20 to 29 years of age,
17.3% (n = 30) were 30 to 39 years of age, 22% (n = 38)
were 40 to 49 years of age, 16.2% (n = 28) were 50 to 59
years of age, and 7% (n = 12) were 60 years of age or older.
Female patients accounted for 30.1% of the population (n =
52). The mean duration of symptoms was 27.7 months
(range, 6-120 months), and the average total follow-up
time was 70.3 months (range, 24-120 months). The major-
ity of the patients had a history of trauma (75.8%), and the
remaining patients reported the onset of ankle pain with-
out any injury or inciting event. More than 80% of the
lesions were smaller than 150 mm2 according to the preop-
erative MRI measurement. The most commonly affected
sites were the medial talar dome, which accounted for
75.7% (131/173) of the cases, and the lateral talar dome,
in the remaining 24.3% (42/173). Associated intra-articular
lesions included soft tissue impingement (70.8%, 122/173),
subchondral cyst (27.8%, 48/173), chronic lateral ankle
instability (21.7%, 37/173), and chondral lesion in the tibial
plafond (13.6%, 23/173). Debridement was performed for
all intra-articular lesions, and removal of loose bodies
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and excision of osteophytes and lateral ligament recon-
struction were performed for specific lesions. The distribu-
tions of ‘‘size of the osteochondral defect’’ and ‘‘associated
intra-articular lesion’’ for the overall patient population are
shown in Table 2. Both of these variables were negatively
correlated with clinical outcome (P\ .0001). As the size of
the osteochondral defect and the number of associated lesions
increased, the postoperative AOFAS score decreased.
Demographics, Size, and Associated
Lesions by Age Group
The gender distribution differed by age group, with a higher
percentage of female patients in the oldest groups (P = .04),
as shown in Appendix 1 (available in the online version of
this article at http://ajs.sagepub.com/supplemental/). The
duration of symptoms increased with each increasing age
(P\ .0001): a mean duration of symptoms was 16.7 months
for patients younger than 20 years and 39 months for
patients 60 years or older. On the other hand, a history of
trauma, including a fall, sprain, or motor vehicle accident,
was less common in older patients (P = .01): 78.9% of patients
younger than age 20 years, 87.1% of patients 20 to 29 years,
75.8% of patients 30 to 39 years, 72.7% of patients 40 to 49
years, 67.9% of patients 50 to 59 years, and 66.7% of patients
60 years or older. Older patients were also less likely to do
outdoor activities than their younger counterparts, suggest-
ing they may have had fewer chances to get injured.
The distributions of ‘‘size of the osteochondral lesion’’
and ‘‘associated intra-articular lesion’’ differed among age
groups (P \ .0001) (Appendix 1, available online). For
the ‘‘size of osteochondral lesion,’’ the distribution shifted
toward the smaller lesions as age increased. The relation-
ship between age and ‘‘associated intra-articular lesion’’
is complex. Patients in the oldest group were more likely
to have soft tissue impingement and a chondral lesion in
the tibial plafond, while patients in the youngest group
were more likely to have chronic lateral ankle instability.
Subchondral cysts were most common in patients aged 30
to 39 years (P\ .0001).
Clinical Outcomes by Age Group
The mean preoperative AOFAS score was 61.38 6 16.74, and
the score increased to 85.376 10.82 postoperatively. The VAS
improved from 7.03 6 1.70 to 2.53 6 1.97 (P\ .0001). How-
ever, no differences were noted among the 6 groups (Table 3).
According to the criteria by Saxena and Eakin,25 successful
outcomes (excellent or good) were observed in 75.0% of
patients younger than 20 years old, 73.3% of patients 20 to
29 years old, 83.3% of patients 30 to 39 years old, 73.6% of
patients 40 to 49 years old, 75.0% of patients 50 to 59 years
old, and 91.7% of patients 60 years or older. There were no
significant differences among groups in the percentage of
patients who had a successful outcome (P = .21).
Multivariate Analysis
We used logistic regression models to assess the indepen-
dent effect of patient age on clinical outcome. The final
model, as shown in Appendix 2 (available online), controls
for gender, duration of symptom, history of trauma, size
and location of the osteochondral defect, and the number
and type of associated intra-articular lesions. When com-
pared with patients younger than 20 years of age, age
was not an independent risk factor for poor clinical out-
come after arthroscopic treatment for OLT (P = .27). In
contrast, the size of the osteochondral defect was an
TABLE 1
Demographics of the Total Patient Population (N = 173)
n %
Age distribution, y
\20 20 11.6
20-29 45 26.0
30-39 30 17.3
40-49 38 22.0
50-59 28 16.2
60 12 6.9
Gender
Male 121 69.9
Female 52 30.1
Duration of symptoms, y
\1 88 50.8
1 85 49.2
Trauma
1 131 75.8
– 42 24.2
Defect size, mm2
\150 146 85.2
150 27 14.8
Location
Medial/lateral 131/42 75.7/24.3
Anterior/middle/posterior 54/70/49 31.2/40.5/28.3
Associated lesion
Soft tissue impingement 122 70.8
Subchondral cyst 48 27.8
Ankle instability 37 21.7
Tibial chondral lesion 23 13.6
TABLE 2
Distribution of ‘‘Size of Osteochondral Defect’’ and
‘‘Number of Associated Lesions’’ and AOFAS Scorea
n % AOFAS Score
Size of osteochondral defect, mm2
\100 102 59.8 92.72 6 11.62
100-149 44 25.4 89.34 6 5.67
150-199 17 9.5 81.56 6 5.75
200 10 5.3 77.85 6 4.29
No. of associated lesions
0 25 14.4 92.16 6 7.82
1 74 42.8 88.69 6 9.72
2 64 37.0 83.74 6 12.16
3 10 5.8 76.89 6 8.63
aP\ .0001 for differences in AOFAS score by ‘‘size of osteochon-
dral defect’’ and ‘‘number of associated lesions.’’ AOFAS, American
Orthopaedic Foot and Ankle Society.
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independent predictor of clinical failure after arthroscopic
treatment (P \ .0001). When compared with patients
with a defect size of\100 mm2, patients with a defect size
of 100 to 149 mm2 were 1.87 times more likely to have clinical
failure after arthroscopic treatment (95% CI, 0.70-4.96).
Meanwhile, patients with a defect size of 150 to 199 mm2
were 6.23 times more likely to have clinical failure (95%
CI, 2.55-15.22), and those with a defect size larger than 200
mm2 were 60.92 times more likely (95% CI, 25.20-147.31).
Other than for patients with soft tissue impingement who
were 2.23 times more likely to have clinical failure than
patients without soft tissue impingement (95% CI, 1.27-
2.87), associated intra-articular lesions were not independent
predictors of clinical outcome. However, the number of asso-
ciated lesions was predictive. As compared with patients
without associated intra-articular lesions, clinical failure
was 1.81 times more likely to be observed in patients with
1 associated intra-articular lesion (95% CI, 1.12-2.93), 2.53
times more likely in patients with 2 lesions (95% CI, 1.53-
4.17), and 4.45 times more likely in patients with 3 lesions
(95% CI, 2.31-8.57). However, gender (P = .17), duration of
symptoms (P = .19), history of trauma (P = .07), and location
of lesion (P = .06 for coronal plane, P = .21 for sagittal plane)
did not independently predict clinical outcome.
DISCUSSION
This is the first study to evaluate the effect of age on the
long-term outcome of patients after arthroscopic treatment
for OLT. In contrast to previous studies that arbitrarily
chose a cutoff to define old or older patients,6,7,10,11,17,24
publishing series as portrayed in Appendix 3 (available
online), our study is unique in that it analyzed 6 different
age groups. This enabled us to demonstrate distinct age-
related trends. In addition, this is the first study that
has a sufficiently large study population to allow the use
of multivariate analysis to assess the independent effect
of age on clinical outcome after arthroscopic treatment
for OLT, thereby controlling for multiple covariates that
may also influence the same outcomes.
Our study shows that older age is not an independent
predictor for clinical failure after arthroscopic treatment
for OLT after controlling for gender, duration of symptom,
history of trauma, size and location of the osteochondral
defect, and the number and type of associated intra-articular
lesions. The duration of symptoms increased along with an
increase in patient age. Older age independently predicted
a lower incidence of trauma, as the incidence of trauma
fell from more than 78% in patients younger than 20 years
of age to less than 67% in patients 60 years and older. Based
on these results, we assumed that patients are less likely to
get injured from outdoor activities as they get older. Like-
wise, the size of the osteochondral defect decreased as
patient age increased. As might be expected, the incidence
of soft tissue impingement and a chondral lesion of the tibial
plafond increased as age increased. A similar pattern was
observed with subchondral cysts, with an exception of the
30- to 39-year-old group with the highest incidence among
the 6 age groups. However, we could not determine any rela-
tionship between patient age and ankle instability.
The observed discrepancies between our data and many
previous studies are likely because of multiple factors. All
of the previous studies were performed with a small num-
ber of patients. While many of them reported poorer clini-
cal outcome in older age groups, they lacked the power to
demonstrate a statistical difference.7,10,11,24 For example,
Ferkel et al10 retrospectively evaluated a total of 64
patients. Twenty-seven patients were 32 years of age or
younger, and 23 were older than 32 years. The older age
group had an AOFAS score of 80, while the younger group
had a score of 88. However, this difference was not signif-
icant. In addition, the age cutoff in most of the previous
studies ranged between 30 to 50 years. On the other
hand, some previous studies demonstrated a significant
difference in clinical outcome.16,17,19,26 In a case series of
72 patients who were arthroscopically treated with micro-
fracture for full-thickness chondral defects in the knee,
Steadman et al26 found that patients younger than 35
years of age improved more than those aged between 35
to 45 years. Furthermore, in a randomized controlled trial
that compared a group undergoing microfracture and
TABLE 3
Clinical Outcomes by Age Groupa
\20 y
(n = 20)
20-29 y
(n = 45)
30-39 y
(n = 30)
40-49 y
(n = 38)
50-59 y
(n = 28)
60 y
(n = 12) P
VAS
Preoperative 7.11 6 1.52 6.38 6 1.95 6.95 6 1.55 7.15 6 1.54 7.38 6 1.74 7.90 6 1.37 .06
Postoperative 1.72 6 1.01 2.61 6 2.00 2.43 6 1.97 2.54 6 1.80 2.84 6 2.39 3.09 6 2.50 .71
AOFAS score
Preoperative 59.78 6 11.63 64.90 6 14.40 64.64 6 16.54 61.36 6 16.59 53.11 6 20.93 61.63 6 19.02 .19
Postoperative 86.31 6 8.58 84.93 6 9.79 88.10 6 7.29 85.86 6 9.78 82.23 6 15.43 84.36 6 15.39 .72
Criteria by Saxena and Eakin25 .21
Excellent 10 (50%) 14 (31.1%) 16 (53.3%) 17 (44.7%) 8 (28.6%) 5 (41.7%)
Good 5 (25%) 19 (42.2%) 9 (30%) 11 (28.9%) 13 (46.4%) 6 (50%)
Fair 5 (25%) 7 (15.6%) 5 (16.7%) 8 (21.1%) 3 (10.7%) 0 (0%)
Poor 0 (0%) 5 (11.1%) 0 (0%) 2 (5.3%) 4 (14.3%) 1 (8.3%)
aVAS, visual analog scale; AOFAS, American Orthopaedic Foot and Ankle Society.
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a group undergoing autologous chondrocyte implantation
in the knee, Knutsen et al16 found better clinical results
in the younger and more active patients (aged\30 years)
in both groups (P = .007).
Through multivariate analysis, we found that age was
not an independent predictor of clinical outcome after
arthroscopic treatment for OLT. In previous in vitro stud-
ies that reported an age-related decline in the number of
mesenchymal stem cells (MSCs) in the bone mar-
row,2,8,18,20 the majority of the decline occurred before
the age of 30 years, with little or no change thereafter.
This is in accordance with our hypothesis that MSCs
from aged patients maintain normal functional capacity
and that there is either no age-related effects on MSCs or
even an age-related increase in MSCs.4,9,20,23
We used ‘‘size of the osteochondral defect’’ and ‘‘associ-
ated intra-articular lesion’’ to control for intra-articular
prognostic factors. The use of the 2 risk factors for poor
prognosis was validated in a study linking the severity of
OLT to clinical outcome.5,6 The use of these 2 variables
as risk factors was further validated in the bivariate anal-
ysis in which both ‘‘size of the osteochondral defect’’ and
‘‘number of intra-articular lesion’’ were strongly correlated
with AOFAS scores. ‘‘Size of the osteochondral defect’’ was
an independent predictor of clinical failure, as clinical
results deteriorated as the size of the osteochondral defect
increased. However, as the age group increased, patients
became more likely to have a smaller osteochondral defect.
This should not be because older patients had less trauma
history or were more likely to be female, as the model con-
trols for both of these factors (as well as several others, see
Appendix 2, available online). We hypothesized that youn-
ger patients are more exposed to sports activities than
older patients, which in turn causes younger patients to
be more likely to have larger osteochondral defects. We
also found in our study that the number of associated
intra-articular lesions was predictive of postoperative out-
come. Interestingly, the presence of each type of intra-
articular lesion, including subchondral cyst, chronic ankle
instability, and chondral lesion of the tibial plafond, did not
correlate with clinical outcome. This suggests that the
complexity of the intra-articular abnormality itself was
responsible for poor clinical outcomes. On the other hand,
soft tissue impingement was found to be associated with
higher rates of clinical failure in our study.
The main shortcoming of the present study is its retro-
spective design. However, given that there are no similar
studies published, we believe that these data are impor-
tant. Furthermore, because this is an ongoing study, this
study could be strengthened in the future, as the number
of patients in the matched groups will increase with time.
To our knowledge, this is one of the largest studies that
evaluated the effects of age on clinical outcome after
arthroscopic treatment for OLT. Older age was not found
to be an independent risk factor for poor clinical outcome
after arthroscopic treatment. For this reason, age alone
should not be a contraindication for arthroscopic treat-
ment, and it is important for surgeons to recognize that
older and younger patients had similar clinical outcomes.
Older patients were more likely to have smaller osteochon-
dral defects, and our data demonstrate that the effect of
trauma on the size of the osteochondral defect is greater
in younger age groups. It will be important to develop algo-
rithms that can carefully select older OLT patients who are
good candidates for arthroscopic treatment and young
patients with large OLT for osteochondral transplantation
to optimize their outcomes. A more in-depth longitudinal
clinical analysis is warranted to further clarify long-term
clinical outcomes of osteochondral transplantation in
patients with OLT in relation with age.
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